Evidence map›Paper›PMID 35387872›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2022

A Ca

Irene Pérez-Liébana, Inés Juaristi, Paloma González-Sánchez, Luis González-Moreno, Eduardo Rial, Maša Podunavac, Armen Zakarian, Jordi Molgó, Ainara Vallejo-Illarramendi, Laura Mosqueira-Martín and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Mitochondrial CaBiomolecules · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Aspartate in the Brain: A Review.Neurochemical research · 2025
    Review
  11. Review
  12. Article
  13. MCU-i4, a mitochondrial CaOncology research · 2025
    Article
  14. NCLX controls hepatic mitochondrial CaMolecular metabolism · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Irene Pérez-LiébanaDepartamento de Biología Molecular, Instituto Universitario de Biología Molecular -IUBM, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain; and Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, 28049, Spain.
Inés JuaristiDepartamento de Biología Molecular, Instituto Universitario de Biología Molecular -IUBM, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain; and Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, 28049, Spain.
Paloma González-SánchezDepartamento de Biología Molecular, Instituto Universitario de Biología Molecular -IUBM, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain; and Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, 28049, Spain.
Luis González-MorenoDepartamento de Biología Molecular, Instituto Universitario de Biología Molecular -IUBM, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain; and Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, 28049, Spain.
Eduardo RialDepartment of Structural and Chemical Biology, Centro de Investigaciones Biológicas Margarita Salas, Madrid, 28040, Spain.ORCID https://orcid.org/0000-0001-8634-8902
Maša PodunavacDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, California 93106.
Armen ZakarianDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, California 93106.
Jordi MolgóUniversité Paris-Saclay, CEA, Institut des Sciences du Vivant Frédéric Joliot, ERL Centre National de la Recherche Scientifique no. 9004, Département Médicaments et Technologies pour la Santé, Service d'Ingénierie Moléculaire pour la Santé, Gif sur Yvette, F-91191, France.
Ainara Vallejo-IllarramendiIIS Biodonostia-University of the Basque Country, Donostia, Spain; CIBERNED (institute Carlos III), Madrid, Spain; and Department of Neurology, Hospital Universitario Donostia-OSAKIDETZA, San Sebastián, 20014, Spain.
Laura Mosqueira-MartínIIS Biodonostia-University of the Basque Country, Donostia, Spain; CIBERNED (institute Carlos III), Madrid, Spain; and Department of Neurology, Hospital Universitario Donostia-OSAKIDETZA, San Sebastián, 20014, Spain.
Adolfo Lopez de MunainIIS Biodonostia-University of the Basque Country, Donostia, Spain; CIBERNED (institute Carlos III), Madrid, Spain; and Department of Neurology, Hospital Universitario Donostia-OSAKIDETZA, San Sebastián, 20014, Spain.
Beatriz PardoDepartamento de Biología Molecular, Instituto Universitario de Biología Molecular -IUBM, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain; and Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, 28049, Spain.
Jorgina SatrústeguiDepartamento de Biología Molecular, Instituto Universitario de Biología Molecular -IUBM, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain; and Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, 28049, Spain jsatrustegui@cbm.csic.es adelarco@cbm.csic.es.
Araceli Del ArcoDepartamento de Biología Molecular, Instituto Universitario de Biología Molecular -IUBM, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain; and Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, 28049, Spain jsatrustegui@cbm.csic.es adelarco@cbm.csic.es.
Consejo Superior de Investigaciones Científicas · ESUniversity of the Basque Country · ESUniversity of California, Santa Barbara · USCentro de Investigaciones Biológicas Margarita Salas · ESCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calcium is an important second messenger regulating a bioenergetic response to the workloads triggered by neuronal activation. In embryonic mouse cortical neurons using glucose as only fuel, activation by NMDA elicits a strong workload (ATP demand)-dependent on Na

Indexed as

Aspartic AcidOxidative PhosphorylationAdenosine TriphosphateAnimalsCalciumGlucoseGlycolysisMalatesMiceNeuronsPyruvatesAdenosine TriphosphateAspartic AcidCalciumGlucoseMalatesPyruvatesAralar/AGC1/Slc25a12calcium regulationglycolysismalate aspartate shuttlemitochondrial calcium uniporterneuronal metabolism

Identifiers

PMID35387872
PMCPMC9097769
OpenAlexW4226255852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.